Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06574087

Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
248 (estimated)
Sponsor
PCK Marine Hospital in Gdynia · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

The primary aim of the study is to determine the total risk of AIN in group of HPV-RGD survivors and additionally to establish an exact risk for each of HPV-related gynecological precancers/cancers. Moreover, the most appropriate screening test for HSIL(AIN) in this group of patients will be determined. It will be effectuated by performing two kinds of tests: hrHPV test for the 14 most common oncogenic HPV types and the liquid cytology from both the lower genital tract and anal canal with subsequent high resolution anoscopy (HRA) with potential biopsy/excision of suspected lesions and histopathological examination.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESThrHPV test and cytologyPerfomance of hrHPV test and cytology

Timeline

Start date
2023-01-13
Primary completion
2027-01-01
Completion
2027-01-01
First posted
2024-08-27
Last updated
2025-07-23

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT06574087. Inclusion in this directory is not an endorsement.